And it turned out that the overall survival (OS) and disease-free survival (DFS) of HCC patients with positive expression of TSPAN9 were both significantly higher than that of HCC patients with negative expression of TSPAN9 (Figures 1(c) and 1(d)). The gene discussed is TSPAN9; the disease is hepatocellular carcinoma.